Khalil G. Saikali
Publications by Year
Research Areas
Erythropoietin and Anemia Treatment, Hemoglobinopathies and Related Disorders, Cardiac pacing and defibrillation studies, Iron Metabolism and Disorders, Microtubule and mitosis dynamics
Most-Cited Works
- → The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial(2011)329 cited
- → Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD(2016)290 cited
- → Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study(2011)260 cited
- → Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study(2016)254 cited
- → Roxadustat (FG-4592)(2015)246 cited
- → A Double-Blind, Randomized, Placebo-Controlled Trial of Escitalopram in the Treatment of Pediatric Depression(2006)209 cited
- → Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases(2012)136 cited
- → Tadalafil has No Detrimental Effect on Human Spermatogenesis or Reproductive Hormones(2003)131 cited
- → Roxadustat for CKD-related Anemia in Non-dialysis Patients(2020)107 cited
- → A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study(2021)96 cited